Cowen Reiterates Outperform on Turning Point Therapeutics (TPTX), Focus Remains on the 1L Updates
Tweet Send to a Friend
Cowen analyst Tyler Van Buren reiterated an Outperform rating on Turning Point Therapeutics Inc. (NASDAQ: TPTX), following the company's most ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
